How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
WEBJun 14, 2024 · GLP-1 receptor agonists also bind to the GLP-1 receptors on certain neurons in the brain to decrease hunger and increase satiety. They have been shown to slow gastric emptying within the first hour of eating, resulting in the feeling of being full. Patients who use GLP-1 receptor agonists experience reduced appetite and hunger, lower preference ...
Type 2 Diabetes Medications That Induce Weight Loss
WEBMar 22, 2024 · A weight loss of 5% to 15% can improve obesity-related complications. 1,2. There are approved medications to help treat obesity, including phentermine (Lomaira®), orlistat (Alli®), topiramate (Trokendi XR®), and naltrexone/bupropion (Contrave®). However, these are not indicated to treat type 2 diabetes. 3.
How Should High Lipoprotein(a) Levels Be Addressed?
WEBOct 29, 2019 · Lp (a) is an independent risk factor for both CV disease and calcific aortic valve stenosis. Serum levels of Lp (a) should be used to determine CV risk linked to Lp (a). HEART UK outlines Lp (a) levels of 32 to 90 nmol/L as being associated with minor risk, 90 to 200 nmol/L associated with moderate risk, 200 to 400 nmol/L associated with high ...
Hyperthyroidism and Thyrotoxicosis: Diagnosis and Management
WEBFeb 19, 2020 · Hyperthyroidism refers to increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis is characterized by the clinical manifestations of inappropriately high thyroid hormone action in tissues. 1 These manifestations result from hormone excess at any level of …
Long-Term Fatigue Is Common After Total Thyroidectomy
WEBNovember 1, 2019. Approximately two-thirds of patients who undergo total thyroidectomy (TT) report new-onset fatigue within the first year after surgery, with only one-third reporting significant improvement over time, according to study results presented at the 89th Annual Meeting of the American Thyroid Association, held October 30 to ...
Improvements in Insulin Resistance With Semaglutide Primarily a …
WEBApr 16, 2019 · Treatment with semaglutide, a once-weekly glucagon-like peptide-1 (GLP-1) analog, consistently reduced body weight and insulin resistance in patients with type 2 diabetes, with improvements in insulin resistance being positively associated with weight loss, according to study results published in The …
Sellar Mass - Endocrinology Advisor
WEBDec 7, 2022 · Sellar masses (SMs) are adenoma bodies that are typically located on or around the pituitary gland, specifically near the sella turcica. 1,2 Sellar masses are known to account for approximately 10% to 15% of all intracranial neoplasms. 3,4 and are responsible for a myriad of visual, neurological, and hormonal deficiencies. 3 …
Is Diabetes Reversible? Reducing Diabetes Symptoms and …
WEBJul 3, 2024 · Diabetes is a chronic condition marked by elevated blood sugar levels. The global prevalence was estimated at 9.3% (463 million people) in 2019 and is projected to increase to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. 1 There are various stages and types of diabetes, such as prediabetes, type 1 diabetes, type 2 …
Central Hypothyroidism - Endocrinology Advisor
WEBNov 17, 2022 · Central hypothyroidism symptoms include 1,2: intolerance to cold and decreased sweating. dry skin and hair. fatigue, drowsiness, and headache. constipation. muscle cramps. changes in sleep and menstrual cycles. unexplained weight gain, along with swelling or puffiness. anxiety, depression, or memory loss.
Diabetes and Diarrhea - Endocrinology Advisor
WEBDiarrhea is a common symptom of diabetes and has a myriad possible causes. Diabetic diarrhea, a subtype of chronic diarrhea, typically occurs in people with severe insulin-dependent diabetes mellitus and who show signs of generalized neuropathy. 1, 2 The term specifically describes chronic diarrhea resulting from secondary effects of diabetic gastroenteropathy. 3 This is a common symptom of ...